Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAP1LC3B2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | BASP1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | COL6A2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | C12orf75 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | CAP2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | SLC27A3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | FBLN5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | TNFRSF21 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | MYBL1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ACER2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |